Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Prediction of adverse events during Intensive Induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes

    ... Intensive chemotherapy for newly diagnosed acute myeloid leukemia (AML) or ... 205 consecutive patients receiving curative-intent induction chemotherapy with cytarabine and an anthracycline ("7+3"; n=175) or a ...

    Research Article last updated 07/20/2018 - 5:15pm.

  2. Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial.

    ... syndromes in complete remission, but post-remission chemotherapy and autologous stem cell transplantation are potential ... evaluated, after intensive anti-leukemic remission-induction chemotherapy, the impact of the availability of an HLA -identical ...

    Research Article last updated 07/20/2018 - 5:14pm.

  3. High-risk myelodysplastic syndromes: chemotherapy, transplantation, and beyond.

    Journal Title:  Curr Hematol Malig Rep Primary Author:  Gergis U Author(s):  ...

    Research Article last updated 07/20/2018 - 5:14pm.

  4. Chemotherapy

    ... How does it work? Chemotherapy for  MDS  patients involves the use of medicines that kill cells cancer cells called cytotoxic agents. Chemotherapy hurts healthy cells along with abnormal ones. So you may need to ...

    Topic section last updated 03/29/2016 - 7:18pm.

  5. Study suggests heart drugs may boost chemotherapy in AML

    ... Acute myeloid leukemia: Heart drugs may boost chemotherapy Article Source:  ... may have identified a way to boost the effect of chemotherapy against one of the most common forms of leukemia in adults: ...

    Article last updated 09/07/2017 - 11:09am.

  6. Let’s Go FISH-ing!

    ... help stop cancer from progressing. It is different from chemotherapy , which affects all fast-growing cells at once. These therapies ...

    Article last updated 08/30/2018 - 1:28pm.

  7. CHIP – A Promising Genetic Discovery for MDS, AML and Cardiovascular Disease

    ... as inflammation, other forms of stress, and exposure to chemotherapy or other toxins may contribute to the likelihood of someone ...

    Article last updated 08/30/2018 - 3:14pm.

  8. Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy.

    ... syndromes in complete remission (CR) after induction chemotherapy . Sixty patients were enrolled and treated by standard induction chemotherapy. Patients that reached CR started maintenance therapy with ...

    Research Article last updated 07/20/2018 - 5:14pm.

  9. Clinical results with the DNA hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update

    ... Due to their lower toxicity compared to conventional chemotherapy , hypomethylating agents are often a safe and feasible ... may play a role in epigenetic "priming" before conventional chemotherapy. This review summarizes the results of clinical trials and ...

    Research Article last updated 07/20/2018 - 5:14pm.

  10. Transplantation strategies for the management of patients with myelodysplastic syndromes.

    ... are almost equal with the results obtained by intensive chemotherapy alone. Failure was due primarily to TRM in patients with ... the procedure. Autologous SCT after successful induction chemotherapy may increase the proportion of long-term survivors, thus ...

    Research Article last updated 07/20/2018 - 5:14pm.